|Bid||0.00 x 900|
|Ask||0.00 x 1000|
|Day's Range||17.83 - 18.74|
|52 Week Range||11.66 - 40.65|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||52.01%|
|Beta (5Y Monthly)||N/A|
|Expense Ratio (net)||0.75%|
CNBS, actively managed by Tim Seymour, is the top-performing U.S.-listed cannabis ETF over the 1-year period ending 3/31/2021 (Source: YCharts)CHICAGO, April 20, 2021 (GLOBE NEWSWIRE) -- Amplify ETFs is pleased to announce the Amplify Seymour Cannabis ETF (NYSE: CNBS) now has the ability to access Multi-State Operators (MSOs) via swaps. The ETF recently completed both legal and operational work in order to add portfolio exposure to this group of companies. “We are excited to now have access to the full plant-touching U.S. cannabis investable universe in the CNBS portfolio at a time when we believe the U.S. market is poised for significant growth,” said Tim Seymour, Portfolio Manager for CNBS.“We are pleased to expand the universe of cannabis market exposure within CNBS,” said Amplify CEO Christian Magoon. “The increase in portfolio flexibility for Tim going forward should further equip CNBS to continue to be the premier way for investors to obtain diversified and professionally-managed exposure to the growing cannabis sector.” CNBS is an ETF investing in the fast-developing global cannabis industry. The Fund is managed by Tim Seymour, a recognized voice and experienced investor in the cannabis space. Investors can learn more at https://amplifyetfs.com/cnbs. Also, Tim Seymour provides his thoughts and insights on the cannabis sector in a weekly audio commentary. Listen and subscribe here: http://bit.ly/345EKxP About Amplify ETFs Amplify ETFs, sponsored by Amplify Investments, has over $4.8 billion in assets across its suite of ETFs (as of 4/15/2021). Amplify believes the ETF structure empowers investors through efficiency, transparency and flexibility. Amplify ETFs deliver expanded investment opportunities for investors seeking growth, income, and managed-risk strategies. Sales Contact:Amplify ETFs855firstname.lastname@example.orgMedia Contact:Gregory FCA for Amplify ETFsKerry Davis610email@example.com CNBS Performance Quarter End as of 3/31/2021Fund Inception Date: 7/23/2019 Cumulative (%)Annualized (%) 1 Mo.3 Mo.6 Mo.YTDSinceInception1 Yr.SinceInception Fund NAV-4.18%66.14%158.73%66.14%18.51%232.80%10.55% Closing Price-3.55%66.48%159.72%66.48%18.93%233.61%10.78% The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Short-term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns. For performance data current to the most recent month-end please call 855-267-3837 or visit https://amplifyetfs.com/cnbs. Brokerage commissions will reduce returns. The Fund’s gross expense ratio is 5.61%, with a 4.86% fee waiver1 that makes the net expense ratio 0.75%. 1Pursuant to an agreement with the Fund, Amplify Investments LLC has agreed to reduce its management fee and effectively reimburse any acquired fund fees incurred by the Fund in an amount that limits the Fund’s “Total Annual Fund Operating Expenses” (excluding taxes, interest, all brokerage commissions, other normal charges incident to the purchase and sale of portfolio securities, distribution and service fees payable pursuant to a Rule 12b-1 plan, and other extraordinary expenses) to not more than 0.75% of the daily net assets of the Fund until March 1, 2022. Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Fund’s statutory and summary prospectus, which may be obtained by calling 855-267-3837 or by visiting AmplifyETFs.com. Read the prospectus carefully before investing. Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV and are not individually redeemed from the Fund. The Fund's return may not match or achieve a high degree of correlation with the return of the underlying Index. The Fund is subject to management risk because it is an actively managed. Companies involved in the cannabis industry face competition, may have limited access to the services of banks, may have substantial burdens on company resources due to litigation, complaints or enforcement actions, and are heavily dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to otherwise cultivate, possess or distribute cannabis. The possession and use of cannabis, even for medical purposes, is illegal under federal and certain states’ laws, which may negatively impact the value of the Fund’s investments. Securities issued by non-U.S. companies present risks beyond those of securities of U.S. issuers. Many of the companies in which the Fund will invest are engaged in other lines of business unrelated to cannabis and these lines of business could adversely affect their operating results. Cannabis is a Schedule I controlled substance under the Controlled Substances Act (“CSA”), meaning that it has a high potential for abuse, has no currently “accepted medical use” in the U.S., lacks accepted safety for use under medical supervision, and may not be prescribed, marketed or sold in the U.S. Small and/or mid-capitalization companies may be more vulnerable to adverse general market or economic developments, and their securities may be less liquid and may experience greater price volatility than larger, more established companies as a result of several factors, including limited trading volumes, products or financial resources, management inexperience and less publicly available information. The Fund is non-diversified, which can cause greater share price fluctuation. Amplify Investments LLC is the Investment Adviser to the Fund, and Penserra Capital Management, LLC serves as the Investment Sub-Adviser. Amplify ETFs are distributed by Foreside Fund Services, LLC.
The cannabis ETF has hit a new 52-week high. Are more gains in store?
Assets surge 285% in 2020 across a diverse and growing product lineupCHICAGO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amplify ETFs announces the firm has accumulated over $3 billion in assets under management since the inception of its first exchange-traded fund (ETF) in 2016. Additionally, the firm’s assets have grown 285% just in 2020 across a diverse product line of ten ETFs, with four ETFs each exceeding $250 million in assets. The product suite of Amplify ETFs encompasses three primary categories: Core ($770 million), Income ($450 million), and Thematic ($1.87 billion). Total firm assets stood at $3.1 billion as of December 28, 2020. “We’re extremely proud of Amplify’s growth to-date, particularly during a year of unprecedented uncertainty and challenging market dynamics,” notes Christian Magoon, CEO of Amplify ETFs and an early advocate of the ETF structure. “We deliver expanded investment strategies for investors seeking growth, income, and capital preservation, and we look forward to continuing that mission.”Several of Amplify’s funds have become market leaders in some of the most competitive ETF peer groups of 2020, including hedged ETFs and online retail. With over $560 million in inflows year-to-date, the Amplify BlackSwan Growth & Treasury Core ETF (NYSE: SWAN) has delivered what it was designed for: to guard against significant losses while also participating in market upside.Additionally, the firm’s flagship fund, the Amplify Online Retail ETF (NYSE: IBUY) at over $1.4 billion in assets, is the first and largest ETF to focus on the growing e-commerce trend. IBUY also has a 5-star Morningstar overall rating based on risk-adjusted returns among 40 funds in the Consumer Cyclical category (as of 9/30/20). IBUY’s sister fund, the Amplify International Online Retail ETF (NYSE: XBUY), also has delivered in 2020 with a focus on e-commerce companies outside the U.S.Other notable Amplify funds that have had strong growth in 2020 include the Amplify Transformational Data Sharing ETF (NYSE: BLOK), Amplify CWP Enhanced Dividend Income ETF (NYSE: DIVO), Amplify Lithium & Battery Technology ETF (NYSE: BATT), and the Amplify Seymour Cannabis ETF (NYSE: CNBS).Amplify ETFs is widely recognized across the ETF industry, securing multiple award nominations from ETF.com and Fund Intelligence in their respective annual award events.For more information about Amplify ETFs’ complete product lineup, visit AmplifyETFs.comContacts Sales Contact: Amplify ETFs 855-267-3837 firstname.lastname@example.orgMedia Contact: Gregory FCA for Amplify ETFs Kerry Davis 610-228-2098 email@example.comCarefully consider the Funds’ investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Funds’ statutory and summary prospectuses, which may be obtained by calling 855-267-3837 or by visiting AmplifyETFs.com. Read the prospectus carefully before investing.Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV and are not individually redeemed from the Fund. The Fund’s return may not match or achieve a high degree of correlation with the return of the underlying Index.For full disclosure on the funds mentioned above, please refer to each Fund’s respective website: IBUY website and Prospectus XBUY website and Prospectus SWAN website and Prospectus DIVO website and Prospectus BLOK website and Prospectus BATT website and Prospectus CNBS website and ProspectusFor a description of the annual ETF.com awards selection process, click here. For a description of the annual Fund Intelligence Mutual Fund & ETF awards selection process, click here.The Morningstar Rating™ for funds, or “star rating”, is calculated for managed products with at least a three-year history. ETFs and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product’s monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The Morningstar Rating does not include any adjustment for sales loads. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.©2020 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.Amplify ETFs are distributed by Foreside Fund Services, LLC.